Immunomedics Inc
IMMU
IMMU was delisted on the 22nd of October, 2020.
220 hedge funds and large institutions have $2.44B invested in Immunomedics Inc in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 81 increasing their positions, 65 reducing their positions, and 54 closing their positions.
80% more call options, than puts
Call options by funds: $28.6M | Put options by funds: $15.9M
25% more repeat investments, than reductions
Existing positions increased: 81 | Existing positions reduced: 65
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
10% less funds holding
Funds holding: 245 → 220 (-25)
33% less capital invested
Capital invested by funds: $3.65B → $2.44B (-$1.22B)
39% less first-time investments, than exits
New positions opened: 33 | Existing positions closed: 54
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$58.9M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$42.5M |
| 3 |
DM
Deerfield Management
New York
|
+$40.1M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$33.9M |
| 5 |
Jennison Associates
New York
|
+$33.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FCMI
Foresite Capital Management III
Larkspur,
California
|
-$22.7M |
| 2 |
Janus Henderson Group
London,
United Kingdom
|
-$18.5M |
| 3 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
-$16.9M |
| 4 |
MS
Maven Securities
St Helier,
Jersey
|
-$16.4M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$15.1M |
IMMU Hedge Fund Activity: Q1 2020 in Review
220 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Immunomedics Inc (IMMU) for Q1 2020, worth a combined $2.44B — down 33% from $3.65B a quarter earlier.
Sellers outnumbered buyers: 54 funds closed out of IMMU and 33 opened new positions — a net loss of 21 holders — while 65 trimmed existing stakes and 81 added.
The largest buyer was Point72 Asset Management, opening a new position worth an estimated $58.9M. The largest seller was Foresite Capital Management III, cutting an estimated $22.7M.
- 220 institutional investors held Immunomedics Inc (IMMU) as of Q1 2020, down from 245 in Q4 2019.
- Funds reported $2.44B of Immunomedics Inc stock for Q1 2020, down 33% quarter-over-quarter.
- 33 funds opened new Immunomedics Inc positions in Q1 2020 and 54 closed out, a net change of -21 holders.
- The largest Immunomedics Inc buyer in Q1 2020 was Point72 Asset Management, an estimated $58.9M added.
- The largest Immunomedics Inc seller in Q1 2020 was Foresite Capital Management III, an estimated $22.7M sold.
Based on aggregated 13F filings for Q1 2020.